Literature DB >> 23199066

Tau pathology: predictive diagnostics, targeted preventive and personalized medicine and application of advanced research in medical practice.

Illana Gozes1.   

Abstract

Microtubules are key cytoskeletal elements found in all eukaryotic cells. The microtubule shaft is composed of the heterodimer protein, tubulin and decorated with multiple microtubule associated protein, regulating microtubule function. Tau (tubulin associated unit) or MAPT (microtubule associated protein tau), among the first microtubule associated proteins to be identified, was implicated in microtubule initiation as well as assembly, with increased expression in neurons and specific association with axonal microtubules. Alzheimer's disease (AD) is the most prevalent tauopathy, exhibiting tau-neurofibrillary tangles associated with cognitive dysfunction. AD is also characterized by β-amyloid plaques. An abundance of tau inclusions, in the absence of β-amyloid deposits, can be found in Pick's disease, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and other diseases, collectively described as tauopathies. The increase in tau pathology in AD correlates with the associated cognitive decline. The current manuscript touches on the variability as well as common denominators of the various tau pathologies coupled to new approaches/current innovation in treatment of tauopathies in favor of advanced technologies in predictive diagnostics, targeted preventive and personalized medicine (PPPM).

Entities:  

Year:  2010        PMID: 23199066      PMCID: PMC3405325          DOI: 10.1007/s13167-010-0029-y

Source DB:  PubMed          Journal:  EPMA J        ISSN: 1878-5077            Impact factor:   6.543


  152 in total

1.  Translation in vitro of rat brain messenger RNA coding for tubulin and actin.

Authors:  I Gozes; H Schmitt; U Z Littauer
Journal:  Proc Natl Acad Sci U S A       Date:  1975-02       Impact factor: 11.205

2.  Tau immunoreactivity in glial cytoplasmic inclusions in multiple system atrophy.

Authors:  A Takeda; N Arai; T Komori; E Iseki; S Kato; M Oda
Journal:  Neurosci Lett       Date:  1997-09-26       Impact factor: 3.046

3.  Tubulin microheterogeneity increases with rat brain maturation.

Authors:  I Gozes; U Z Littauer
Journal:  Nature       Date:  1978-11-23       Impact factor: 49.962

4.  Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.

Authors:  D Testa; D Monza; M Ferrarini; P Soliveri; F Girotti; G Filippini
Journal:  Neurol Sci       Date:  2001-06       Impact factor: 3.307

5.  Association of an extended haplotype in the tau gene with progressive supranuclear palsy.

Authors:  M Baker; I Litvan; H Houlden; J Adamson; D Dickson; J Perez-Tur; J Hardy; T Lynch; E Bigio; M Hutton
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

6.  Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

Authors:  Adam L Boxer; Michael D Geschwind; Nataliya Belfor; Maria Luisa Gorno-Tempini; Guido F Schauer; Bruce L Miller; Michael W Weiner; Howard J Rosen
Journal:  Arch Neurol       Date:  2006-01

7.  Heterogeneous nuclear ribonucleoprotein E3 modestly activates splicing of tau exon 10 via its proximal downstream intron, a hotspot for frontotemporal dementia mutations.

Authors:  Yan Wang; Lei Gao; Sze-Wah Tse; Athena Andreadis
Journal:  Gene       Date:  2009-11-12       Impact factor: 3.688

Review 8.  Tau phosphorylation: the therapeutic challenge for neurodegenerative disease.

Authors:  Diane P Hanger; Brian H Anderton; Wendy Noble
Journal:  Trends Mol Med       Date:  2009-02-24       Impact factor: 11.951

9.  Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's disease.

Authors:  M Goedert; M G Spillantini; R Jakes; D Rutherford; R A Crowther
Journal:  Neuron       Date:  1989-10       Impact factor: 17.173

10.  The structure of the tau haplotype in controls and in progressive supranuclear palsy.

Authors:  Alan M Pittman; Amanda J Myers; Jaime Duckworth; Leslie Bryden; Melissa Hanson; Patrick Abou-Sleiman; Nicholas W Wood; John Hardy; Andrew Lees; Rohan de Silva
Journal:  Hum Mol Genet       Date:  2004-04-28       Impact factor: 6.150

View more
  6 in total

1.  Tau Diagnostics and Clinical Studies.

Authors:  Illana Gozes; Günter Höglinger; James P Quinn; Nigel M Hooper; Kina Höglund
Journal:  J Mol Neurosci       Date:  2017-10       Impact factor: 3.444

2.  Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory.

Authors:  N Amram; G Hacohen-Kleiman; S Sragovich; A Malishkevich; J Katz; O Touloumi; R Lagoudaki; N C Grigoriadis; E Giladi; A Yeheskel; M Pasmanik-Chor; Y Jouroukhin; I Gozes
Journal:  Mol Psychiatry       Date:  2016-01-19       Impact factor: 15.992

Review 3.  Specific protein biomarker patterns for Alzheimer's disease: improved diagnostics in progress.

Authors:  Illana Gozes
Journal:  EPMA J       Date:  2017-09-04       Impact factor: 6.543

4.  Integrative genomic analysis of PPP3R1 in Alzheimer's disease: a potential biomarker for predictive, preventive, and personalized medical approach.

Authors:  Chuansheng Zhao; Mei Zhao; Zhike Zhou; Jun Bai; Shanshan Zhong; Rongwei Zhang; Kexin Kang; Xiaoqian Zhang; Ying Xu
Journal:  EPMA J       Date:  2021-11-15       Impact factor: 6.543

5.  Molecular Signatures of Mitochondrial Complexes Involved in Alzheimer's Disease via Oxidative Phosphorylation and Retrograde Endocannabinoid Signaling Pathways.

Authors:  Fenqin Chen; Jun Bai; Shanshan Zhong; Rongwei Zhang; Xiaoqian Zhang; Ying Xu; Mei Zhao; Chuansheng Zhao; Zhike Zhou
Journal:  Oxid Med Cell Longev       Date:  2022-04-05       Impact factor: 6.543

6.  Neurodegeneration: accelerated ageing or inadequate healthcare?

Authors:  Olga Golubnitschaja
Journal:  EPMA J       Date:  2010-06-29       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.